Should we routinely add CRP to clozapine titrations? - Learning from three cases.

Shelton, Charles; Ruan, Can-Jun; Ertugrul, Aygün; Cotes, Robert O; De Leon, Jose

Shelton, Charles; Ruan, Can-Jun; Ertugrul, Aygün; Cotes, Robert O; De Leon, Jose.

Afiliação

Shelton C; Eastern State Hospital, and the Department of Psychiatry, University of Kentucky, Lexington, KY, USA.
Ruan CJ; Laboratory of Clinical Psychopharmacology and The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
Ertugrul A; Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Cotes RO; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
De Leon J; Eastern State Hospital, and the Department of Psychiatry, University of Kentucky, Lexington, KY, USA.

Neuropsychopharmacol Hung ; 24(4): 153-161, 2022 12 01.

Article em En | MEDLINE | ID: mdl-36775960

Assuntos

Antipsicóticos; Clozapina; Miocardite; Adulto; Feminino; Humanos; Masculino; Antipsicóticos/efeitos adversos; Clozapina/efeitos adversos; Inflamação/induzido quimicamente; Miocardite/induzido quimicamente; Miocardite/diagnóstico; Estudos Prospectivos; Proteína C-Reativa

Palavras-chave

CYP1A2; clozapine/adverse effects; clozapine/blood; clozapine/metabolism; inflammation; myocarditis/chemically induced; myocarditis/etiology

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antipsicóticos / Clozapina / Miocardite Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Neuropsychopharmacol Hung Ano de publicação: 2022 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links